Revance Therapeutics | RVNC - Ação



Ação Alterar Data
AbbVie USD 4.95B 13M 2025-12
ALKERMES USD 196.62M 5.63M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Cara Therapeutics USD 900K 0 2025-03
Coherus Biosciences USD 3.17M 1.12M 2025-12
Eli Lilly USD 13.74B 1.56B 2025-12
J&J USD 14.19B 45M 2025-12
Merck USD 6.44B 157M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
P&G USD 7.82B 31M 2025-12
Pacira USD 152.86M 4.82M 2025-12
Supernus Pharmaceuticals USD 107.1M 63.08M 2025-09